Table 6 ELISA results from the complete 116 sera and two further scarring case-control studies. The three arrayed antigens were tested on the complete set of 116 sera (2006), 231 samples from a previous scarring case-control study in The Gambia (1995) and a subsequent scarring case-control study in The Gambia (2011). CT442 showed no association with the absence of scarring, and CT667/CT706 were not associated with scarring

0.24 (0.19–0.33)

0.27 (0.18–0.33)

0.368

0.33 (0.02–3.36)

0.29 (0.18–0.43)

0.30 (0.15–0.46)

0.990

1.00 (0.46–2.13)

0.31 (0.22–0.38)

0.36 (0.24–0.48)

0.023

36.19 (2.20–1109.21)

0.04 (0.03–0.06)

0.04 (0.03–0.07)

0.169

2766.28 (0.06–6.20 × 10⁸)

0.14 (0.05–0.23)

0.12 (0.03–0.23)

0.344

0.59 (0.18–1.68)

0.03 (0.02–0.06)

0.03 (0.02–0.07)

0.802

0.23 (2.47 × 10^-6–24,634.90)

0.05 (0.03–0.07)

0.04 (0.03–0.06)

0.289

42.59 (0.07–1.26 × 10⁵)

0.14 (0.06–0.23)

0.12 (0.04–0.23)

0.307

0.58 (0.18–1.57)

0.02 (0.02–0.06)

0.03 (0.02–0.08)

0.940

1.24 (0.005–619.41)